Clinical Trial Update: Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy and safety of Beclomethasone dipropionate HFA nasal aerosol in patients 12 years and older with seasonal allergic rhinitis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Beclomethasone dipropionate HFA nasal aerosol (Beclomethasone dipropionate)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Seasonal Allergic Rhinitis, Hayfever | Phase 2 | Status: COMPLETED | Results posted: 2012-05-22